Business
Ventripoint to Sponsor Advanced Imaging 2023 in London, England
(TheNewswire) Toronto, Ontario – The Newswire – July 11, 2023 - Ventripoi...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint to Sponsor Advanced Imaging 2023 in London, England\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario – The Newswire –\nJuly 11, 2023\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \") (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF), is pleased to announce its participation as a\nsponsor in Advanced Imaging 2023: Pericardial Disease, a prestigious\njoint meeting sponsored by the British Society of Echocardiography and\nthe Royal Society of Medicine.  The event is scheduled to take place\nin London, England on July 18, 2023. The conference promises a\ncomprehensive overview of multimodality imaging and intervention for\npericardial disease. Ventripoint’s VMS+ solution provides physicians\nwith real-time volume data to monitor the treatment and progression of\npericardial disease.\n \n \n \n \n This is Ventripoint’s inaugural attendance at this\nconference as partner of the British Society of Echocardiography.\n The company is thrilled to be part of this esteemed gathering\nalongside Ventripoint’s distribution partner, Cardiologic.\nVentripoint looks forward to joining the conversation\n \n \n and showcasing our products alongside other\n \n \n cutting-edge solutions in cardiac imaging and intervention\nfor cardiac disease.\n \n \n We endeavor to partner with\nworld class physicians and hospitals alike to provide innovative\ndiagnostic and treatment solutions that elevate cardiac care by\nimproving the patient experience.\n \n \n \n \n Advanced Imaging 2023 serves as a unique platform where\nleading professionals, researchers, and healthcare practitioners can\ncollaborate and exchange knowledge, advancements, and best practices\nin the field of multimodality imaging and intervention for pericardial\ndisease. It is very important for pericardial disease to be detected\nand managed with precise imaging in order to provide effective\ntreatment. With the overarching goal of advancing patient care and\ncardiovascular health for pericardial disease, the conference offers a\ndiverse program of lectures and interactive case discussions.\n \n \n \n \n Ventripoint’s VMS+ family of products enable precise\nand accurate volumetric analysis of the heart, p...